Our first postdoctoral hire is complete! Welcoming James Tribble, PhD, from the lab of Prof. James Morgan at Cardiff University, School of Optometry and Vision Sciences. James' work focuses on the early pathogenesis of glaucoma, especially the role of dendritic and synaptic degeneration in mouse, rat, and human glaucomas. We are very pleased to have … Continue reading Welcoming James Tribble, PhD to the Pete Williams Lab
Read out new short report in Communicative & Integrative Biology! Williams PA, Harder JM, Cardozo BH, Foxworth NE, John SWM. “Nicotinamide treatment robustly protects from inherited mouse glaucoma”. Communicative & Integrative Biology. 2018 (doi: 10.1080/19420889.2017.1356956) [pdf]
Pete spoke and chaired a session at the EVER Optic Nerve Meeting, 2017. See his talk here: [pdf]
Read out new review out now in J Glaucoma. Williams PA, Harder JM, John SWM. “Glaucoma as a metabolic optic neuropathy: making the case for nicotinamide treatment in glaucoma”. Journal of Glaucoma. 2017 (doi: 10.1097/IJG.0000000000000767) [pdf]
Pete Williams has been awarded faculty funding as an assistant professor by the Karolinska Institutet Board of Research, 2017 (4.75 MSEK). Pete will take up his new post in 2018.
Pete spoke at the 2017 WGC, Helsinki on June 29th, 2017. See his talk here: [pdf]
Our recent paper in Science was featured in NEJM.
Read our newest manuscript in Frontiers in Neuroscience! Williams PA, Harder JM, Foxworth NE, Cardozo BH, John SWM. “Nicotinamide and WLDS act together to prevent neurodegeneration in glaucoma”. Frontiers in Neuroscience. 2017 (doi: 10.3389/fnins.2017.00232) [pdf]
Vitamin B3 protects mice from glaucoma [From Science] Glaucoma is the most common cause of age-related blindness in the United States. There is currently no cure, and once vision is lost, the condition is irreversible. Williams et al. now report that vitamin B3 (also known as niacin) prevents eye degeneration in glaucoma-prone mice (see the … Continue reading New manuscript in Science